1339892-29-3

Upstream product

• 1339891-11-0 7-chloro-5-(methylsulfanyl)imidazo[1,2-c]pyrimidine hydrochloride 
• 1339892-22-6 7-(4-morpholinophenyl)imidazo[1,2-c]pyrimidin-5(6H)-one 
• 1339892-21-5 4-(4-(5-(methylthio)imidazo[1,2-c]pyrimidin-7-yl)phenyl)morpholine 
• 936250-20-3 5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole 
• 1339892-24-8 4-(4-(5-chloroimidazo[1,2-c]pyrimidin-7-yl)phenyl)morpholine 

Relevant academic research and scientific papers

5, 7-SUBSTITUTED-IMIDAZO [1, 2-C] PYRIMIDINES AS INHIBITORS OF JAK KINASES

Compounds of Formula I: (Formula should be inserted here) and stereoisomers and pharmaceutically acceptable salts and solvates thereof in which R1, R2, R3, R4, R5, R6, R7, X1 and X2 have the meanings given in the specification, are inhibitors of one or more JAK kinases and are useful in the treatment of autoimmune diseases, inflammatory diseases, rejection of transplanted organs, tissues and cells, as well as hematologic disorders and malignancies and their co-morbidities.